Procurement of Life Saving Medicines for FY 2026-27 at Cantt General Hospital Rawalpindi

Rawalpindi Cantonment Board, through Cantt General Hospital Rawalpindi, invites eligible manufacturers, authorized importers, distributors, dealers and suppliers to submit bids for the procurement of life saving medicines for the financial year 2026-27. This procurement is conducted under the Single Stage-Two Envelope procedure through the E-PADS V2.0 electronic bidding system. The medicines are to be supplied to Cantt General Hospital, Rawalpindi Cantt, with delivery locations including the Main Store, Pharmacy, Laboratory, and relevant departments within the hospital. Items being procured include a comprehensive list of essential medicines such as Diclofenac Sodium 50mg Tab (6000 units), Diclofenac Sodium 75mg Inj (4000 units), Ketorolac 30mg/ml Inj (1000 units), Mefenamic acid 250mg Tab (6000 units), Paracetamol + Orphenadrine Citrate Tab (6000 units), Paracetamol 1g Inj (1000 units), Aceclofenac 100mg Tab (500 units), Ibuprofen 100mg/5ml Syp (1000 units), Pregabalin 75mg Cap (3000 units), Paracetamol 500 Tab (30000 units), Tramadol 100mg Inj (400 units), Nalbuphine 10mg Inj (300 units), Isoflurane 100ml Inj (200 units), Bupivacaine Spinal 2ml Inj (600 units), Atracurium 50mg Inj (300 units), Lignocaine 2% 10ml Inj (2000 units), Ketamine 500mg Inj (50 units), and many more totaling over 160 different medicines. The technical scope requires all medicines to be new, genuine, and compliant with DRAP regulations, including valid product registration, batch traceability, minimum 12 months shelf life at delivery, and adherence to quality standards. Cold-chain items must be transported under validated temperature conditions. Suppliers must provide valid licenses, maintain stock availability, and ensure timely delivery within 27 days of supply orders. Rejected or defective items must be replaced at the supplier's cost within the specified period. Eligibility criteria include valid Drug Sale or Distribution License (Category A), registration with FBR and appearance on the Active Taxpayer List (ATL), minimum three years of relevant supply experience, and no blacklisting or suspension history. Bidders must submit a bid security of 2% of the estimated cost for each lot/category. Technical evaluation will be based on compliance, experience, financial capacity, and past performance, with a minimum passing score of 70 out of 100. Key dates include bid submission deadline on 07-09-2026 at 11:00 a.m. and technical bid opening on the same day at 11:30 a.m. Bids must be submitted electronically via E-PADS, with original bid security submitted before technical bid opening. The procuring agency address for correspondence is The Mall Road, Opposite AWT Plaza, Rawalpindi Cantonment Board, Rawalpindi Cantt. A practical tip for bidders is to ensure all technical documents and compliance schedules are complete and submitted timely through E-PADS, with no price information included in the technical proposal to avoid disqualification. Maintaining valid licenses and ensuring product registration with DRAP will significantly enhance bid responsiveness. This procurement offers a significant opportunity for suppliers specialized in pharmaceutical products to serve a major healthcare institution in Rawalpindi with a contract value estimated at Rs. 8.519 million.